Cited by 110HIV Research and TreatmentT-cell and Retrovirus StudiesHIV/AIDS Research and Interventions

Siglec-1 initiates formation of the virus-containing compartment and enhances macrophage-to-T cell transmission of HIV-1

Open access
Hammonds, Jason E., Beeman, Neal, Ding, Lingmei, Takushi, Sarah, Francis, Ashwanth C., Wang, Jaang-Jiun, Melikyan, Gregory B., Spearman, Paul·2017·PLOS Pathogens

Abstract

HIV-1 particles assemble and bud from the plasma membrane of infected T lymphocytes. Infected macrophages, in contrast, accumulate particles within an apparent intracellular compartment known as the virus-containing compartment or VCC. Many aspects of the formation and function of the VCC remain unclear. Here we demonstrate that VCC formation does not actually require infection of the macrophage, but can be reproduced through the exogenous addition of non-infectious virus-like particles or infectious virions to macrophage cultures. Particles were captured by Siglec-1, a prominent cell surface lectin that attaches to gangliosides on the lipid envelope of the virus. VCCs formed within infected macrophages were readily targeted by the addition of ganglioside-containing virus-like particles to the extracellular media. Depletion of Siglec-1 from the macrophage or depletion of gangliosides from viral particles prevented particle uptake into the VCC and resulted in substantial reductions of VCC volume. Furthermore, Siglec-1-mediated virion capture and subsequent VCC formation was required for efficient trans-infection of autologous T cells. Our results help to define the nature of this intracellular compartment, arguing that it is a compartment formed by particle uptake from the periphery, and that this compartment can readily transmit virus to target T lymphocytes. Inhibiting or eliminating the VCC may be an important component of strategies to reduce HIV transmission and to eradicate HIV reservoirs.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.ppat.1006181

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • HIV-1 viral particles are translocated from the VCC to the IS for transmission.

    “Then, HIV-1 viral particles are translocated from the VCC to the IS for transmission.”

    From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [85]

    The Results section on trans-infection says virions retained in the VCC can subsequently contribute to transmission to T cells. The Discussion also refers to subsequent transmission at a virologic synapse, but it does not establish the claimed translocation of particles from the VCC to the IS. (LLM, conf=0.84)

    Experimental — accuracy not yet measured
  • HIV-1 viral particles in complex with Siglec-1 accumulate in VCCs, where they are protected from lysosomal degradation and neutralizing antibodies.

    “In complex with Siglec-1, HIV-1 viral particles accumulate in deep invaginations of the plasma membrane, known as virus-containing compartments (VCCs), where they are protected from lysosomal degradation and neutralizing antibodies [85,88].”

    From HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread (2022) · cites this paper as [85]

    The Results (no page number provided) show that HIV-1 particles and Siglec-1 colocalize in macrophage VCCs. The Introduction describes VCCs as plasma-membrane-connected and non-acidic, with limited antibody accessibility, but cautions that antibody protection may be incomplete. Our copy does not establish protection from lysosomal degradation, so the claim overstates what this paper supports. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • CD169/Siglec-1 mediates uptake and transmission of HIV-1.

    “Another molecule that mediates the uptake and transmission of HIV-1 is the type I lectin receptor CD169/sialic acid-binding immunoglobulin-type lectin 1 (Siglec-1).”
  • Siglec-1 is expressed on activated mature DCs and macrophages and binds to GM3 ganglioside in the HIV-1 viral envelope.

    “This receptor is expressed on the surface of activated mature DCs and macrophages, and binds to the GM3 ganglioside in the HIV-1 viral envelope [85,86,87].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 39

  1. [1]Tan J, Sattentau QJ. The HIV-1-containing macrophage compartment: a perfect cellular niche? Trends in microbiology. 2013; 21(8): 405– 12. 10.1016/j.tim.2013.05.001 23735804 · DOI
  2. [2]Cribbs SK, Lennox J, Caliendo AM, Brown LA, Guidot DM. Healthy HIV-1-infected individuals on highly active antiretroviral therapy harbor HIV-1 in their alveolar macrophages. AIDS research and human retroviruses. 2015; 31(1): 64– 70. 10.1089/AID.2014.0133 25134819 PMC4287110 · DOI
  3. [3]Watters SA, Mlcochova P, Gupta RK. Macrophages: the neglected barrier to eradication. Current opinion in infectious diseases. 2013; 26(6): 561– 6. 10.1097/QCO.0000000000000014 24152764 · DOI
  4. [5]Deneka M, Pelchen-Matthews A, Byland R, Ruiz-Mateos E, Marsh M. In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53. The Journal of cell biology. 2007; 177(2): 329– 41. 10.1083/jcb.200609050 17438075 PMC2064140 · DOI
  5. [6]Pelchen-Matthews A, Kramer B, Marsh M. Infectious HIV-1 assembles in late endosomes in primary macrophages. The Journal of cell biology. 2003; 162(3): 443– 55. 10.1083/jcb.200304008 12885763 PMC2172706 · DOI
  6. [7]Raposo G, Moore M, Innes D, Leijendekker R, Leigh-Brown A, Benaroch P, et al Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic. 2002; 3(10): 718– 29. 12230470
  7. [8]Bennett AE, Narayan K, Shi D, Hartnell LM, Gousset K, He H, et al Ion-abrasion scanning electron microscopy reveals surface-connected tubular conduits in HIV-infected macrophages. PLoS pathogens. 2009; 5(9): e1000591 10.1371/journal.ppat.1000591 19779568 PMC2743285 · DOI · Paper page
  8. [9]Gaudin R, Berre S, Cunha de Alencar B, Decalf J, Schindler M, Gobert FX, et al Dynamics of HIV-containing compartments in macrophages reveal sequestration of virions and transient surface connections. PloS one. 2013; 8(7): e69450 10.1371/journal.pone.0069450 23922713 PMC3726685 · DOI
  9. [10]Jouve M, Sol-Foulon N, Watson S, Schwartz O, Benaroch P. HIV-1 buds and accumulates in "nonacidic" endosomes of macrophages. Cell host & microbe. 2007; 2(2): 85– 95. 18005723
  10. [11]Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, Krausslich HG. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS pathogens. 2007; 3(3): e36 10.1371/journal.ppat.0030036 17381240 PMC1829407 · DOI
  11. [12]Nkwe DO, Pelchen-Matthews A, Burden JJ, Collinson LM, Marsh M. The intracellular plasma membrane-connected compartment in the assembly of HIV-1 in human macrophages. BMC Biol. 2016; 14: 50 10.1186/s12915-016-0272-3 27338237 PMC4919869 · DOI
  12. [13]Chu H, Wang JJ, Qi M, Yoon JJ, Wen X, Chen X, et al The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules. PloS one. 2012; 7(5): e35297 Epub 2012/05/09. 10.1371/journal.pone.0035297 22567100 PMC3342280 · DOI
  13. [14]Koppensteiner H, Banning C, Schneider C, Hohenberg H, Schindler M. Macrophage internal HIV-1 is protected from neutralizing antibodies. Journal of virology. 2012; 86(5): 2826– 36. 10.1128/JVI.05915-11 22205742 PMC3302290 · DOI
  14. [15]Chu H, Wang JJ, Qi M, Yoon JJ, Chen X, Wen X, et al Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. Cell host & microbe. 2012; 12(3): 360– 72. 22980332 PMC3444820
  15. [16]Giese S, Marsh M. Tetherin can restrict cell-free and cell-cell transmission of HIV from primary macrophages to T cells. PLoS pathogens. 2014; 10(7): e1004189 10.1371/journal.ppat.1004189 24991932 PMC4081785 · DOI
  16. [17]Izquierdo-Useros N, Naranjo-Gomez M, Archer J, Hatch SC, Erkizia I, Blanco J, et al Capture and transfer of HIV-1 particles by mature dendritic cells converges with the exosome-dissemination pathway. Blood. 2009; 113(12): 2732– 41. 10.1182/blood-2008-05-158642 18945959 PMC2661860 · DOI
  17. [18]Hatch SC, Archer J, Gummuluru S. Glycosphingolipid composition of human immunodeficiency virus type 1 (HIV-1) particles is a crucial determinant for dendritic cell-mediated HIV-1 trans-infection. Journal of virology. 2009; 83(8): 3496– 506. 10.1128/JVI.02249-08 19193785 PMC2663285 · DOI
  18. [19]Puryear WB, Yu X, Ramirez NP, Reinhard BM, Gummuluru S. HIV-1 incorporation of host-cell-derived glycosphingolipid GM3 allows for capture by mature dendritic cells. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109(19): 7475– 80. 10.1073/pnas.1201104109 22529395 PMC3358844 · DOI
  19. [20]Puryear WB, Akiyama H, Geer SD, Ramirez NP, Yu X, Reinhard BM, et al Interferon-inducible mechanism of dendritic cell-mediated HIV-1 dissemination is dependent on Siglec-1/CD169. PLoS pathogens. 2013; 9(4): e1003291 10.1371/journal.ppat.1003291 23593001 PMC3623718 · DOI · Paper page
  20. [21]Izquierdo-Useros N, Lorizate M, McLaren PJ, Telenti A, Krausslich HG, Martinez-Picado J. HIV-1 capture and transmission by dendritic cells: the role of viral glycolipids and the cellular receptor Siglec-1. PLoS pathogens. 2014; 10(7): e1004146 10.1371/journal.ppat.1004146 25033082 PMC4102576 · DOI
  21. [22]Zou Z, Chastain A, Moir S, Ford J, Trandem K, Martinelli E, et al Siglecs facilitate HIV-1 infection of macrophages through adhesion with viral sialic acids. PloS one. 2011; 6(9): e24559 10.1371/journal.pone.0024559 21931755 PMC3169630 · DOI
  22. [23]Erikson E, Wratil PR, Frank M, Ambiel I, Pahnke K, Pino M, et al Mouse Siglec-1 Mediates trans-Infection of Surface-bound Murine Leukemia Virus in a Sialic Acid N-Acyl Side Chain-dependent Manner. J Biol Chem. 2015; 290(45): 27345– 59. 10.1074/jbc.M115.681338 26370074 PMC4646371 · DOI
  23. [24]Sewald X, Ladinsky MS, Uchil PD, Beloor J, Pi R, Herrmann C, et al Retroviruses use CD169-mediated trans-infection of permissive lymphocytes to establish infection. Science. 2015; 350(6260): 563– 7. 10.1126/science.aab2749 26429886 PMC4651917 · DOI
  24. [25]Pino M, Erkizia I, Benet S, Erikson E, Fernandez-Figueras MT, Guerrero D, et al HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells. Retrovirology. 2015; 12: 37 10.1186/s12977-015-0160-x 25947229 PMC4423124 · DOI
  25. [27]Pickering S, Hue S, Kim EY, Reddy S, Wolinsky SM, Neil SJ. Preservation of tetherin and CD4 counter-activities in circulating Vpu alleles despite extensive sequence variation within HIV-1 infected individuals. PLoS pathogens. 2014; 10(1): e1003895 10.1371/journal.ppat.1003895 24465210 PMC3900648 · DOI
  26. [28]Nowicka-Sans B, Gong YF, McAuliffe B, Dicker I, Ho HT, Zhou N, et al In vitro antiviral characteristics of HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068. Antimicrob Agents Chemother. 2012; 56(7): 3498– 507. 10.1128/AAC.00426-12 22547625 PMC3393465 · DOI
  27. [29]Si Z, Madani N, Cox JM, Chruma JJ, Klein JC, Schon A, et al Small-molecule inhibitors of HIV-1 entry block receptor-induced conformational changes in the viral envelope glycoproteins. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(14): 5036– 41. 10.1073/pnas.0307953101 15051887 PMC387369 · DOI
  28. [30]Gobeil LA, Lodge R, Tremblay MJ. Macropinocytosis-like HIV-1 internalization in macrophages is CCR5 dependent and leads to efficient but delayed degradation in endosomal compartments. Journal of virology. 2013; 87(2): 735– 45. 10.1128/JVI.01802-12 23115275 PMC3554056 · DOI
  29. [31]Marechal V, Prevost MC, Petit C, Perret E, Heard JM, Schwartz O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. Journal of virology. 2001; 75(22): 11166– 77. 10.1128/JVI.75.22.11166-11177.2001 11602756 PMC114696 · DOI
  30. [32]Arrildt KT, LaBranche CC, Joseph SB, Dukhovlinova EN, Graham WD, Ping LH, et al Phenotypic Correlates of HIV-1 Macrophage Tropism. Journal of virology. 2015; 89(22): 11294– 311. 10.1128/JVI.00946-15 26339058 PMC4645658 · DOI
  31. [33]Blanchet FP, Stalder R, Czubala M, Lehmann M, Rio L, Mangeat B, et al TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse. Retrovirology. 2013; 10: 6 10.1186/1742-4690-10-6 23311681 PMC3561259 · DOI
  32. [34]Coleman CM, Spearman P, Wu L. Tetherin does not significantly restrict dendritic cell-mediated HIV-1 transmission and its expression is upregulated by newly synthesized HIV-1 Nef. Retrovirology. 2011; 8: 26 10.1186/1742-4690-8-26 21504576 PMC3108291 · DOI
  33. [35]Hammonds J, Wang JJ, Yi H, Spearman P. Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane. PLoS pathogens. 2010; 6(2): e1000749 Epub 2010/02/09. 10.1371/journal.ppat.1000749 20140192 PMC2816691 · DOI
  34. [36]Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. Journal of virology. 1990; 64(2): 621– 9. 2404139 PMC249152
  35. [37]Burns JC, Friedmann T, Driever W, Burrascano M, Yee JK. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proceedings of the National Academy of Sciences of the United States of America. 1993; 90(17): 8033– 7. 8396259 PMC47282
  36. [38]Khan MA, Aberham C, Kao S, Akari H, Gorelick R, Bour S, et al Human immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA. Journal of virology. 2001; 75(16): 7252– 65. 10.1128/JVI.75.16.7252-7265.2001 11461998 PMC114961 · DOI
  37. [39]Seaman MS, Janes H, Hawkins N, Grandpre LE, Devoy C, Giri A, et al Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. Journal of virology. 2010; 84(3): 1439– 52. 10.1128/JVI.02108-09 19939925 PMC2812321 · DOI
  38. [40]Barlow AL, Macleod A, Noppen S, Sanderson J, Guerin CJ. Colocalization analysis in fluorescence micrographs: verification of a more accurate calculation of pearson's correlation coefficient. Microscopy and microanalysis: the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada. 2010; 16(6): 710– 24. 20946701
  39. [41]Huang Y, Kong WP, Nabel GJ. Human immunodeficiency virus type 1-specific immunity after genetic immunization is enhanced by modification of Gag and Pol expression. Journal of virology. 2001; 75(10): 4947– 51. 10.1128/JVI.75.10.4947-4951.2001 11312370 PMC114253 · DOI

Cited by

Sorted by citations

Authors
Hammonds, J. E., Beeman, N., Ding, L., Takushi, S., Francis, A. C., Wang, J.-J., Melikyan, G. B., & Spearman, P.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Emory University (US)
Corresponding author
Spearman, Paul
Venue
PLOS Pathogens
Published
2017-01-27
Volume
13
Issue
1
Pages
e1006181
ISSN
  • 1553-7366 (ISSN-L)
  • 1553-7374
OpenAlex
W2580578756
Cited by
110
References
2
Citations by year
2026: 8 · 2025: 12 · 2024: 9 · 2023: 14 · 2022: 13 · 2021: 10 · 2020: 13 · 2019: 14 · 2018: 5 · 2017: 11
FWCI
6.40
Type
journal article
Language
en
Open access
Locations
  • PLoS Pathogens (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Figshare (submittedVersion, cc-by)
Funders
National Institute of Allergy and Infectious Diseases (AI058858)
Topics
  • Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
Siglec-1, HIV-1, macrophages, trans-infection, T cell infection, gangliosides, virus-like particles, cell surface lectins, HIV reservoir, virus transmission
MeSH terms
Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Humans, Inclusion Bodies, Viral, Macrophages, Microscopy, Fluorescence, Virion, CD4-Positive T-Lymphocytes, HIV-1, HIV Infections, Microscopy, Electron, Transmission, Time-Lapse Imaging, Sialic Acid Binding Ig-like Lectin 1

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review